Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMI 1195 Imaging in Heart Failure
NCT01085175Phase 2Withdrawn
- Sponsor
- Lantheus Holdings, Inc.
- Start
- May 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flubrobenguane F18 in heart failure (HF), sponsored by Lantheus Holdings, Inc.. Planned start May 2010; status: withdrawn.
02
Drugs
flubrobenguane F18
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01085175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085175.